Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension

被引：0
|
作者：
Jayasekera, Geeshath
Johnson, Martin
Church, Colin
Peacock, Andrew
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Pulmonary hypertension; Circulation; Chronic disease;
D O I：
10.1183/13993003.congress-2016.PA1876
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1876
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
    Roberts, JD
    Fineman, JR
    Morin, FC
    Shaul, PW
    Rimar, S
    Schreiber, MD
    Polin, RA
    Zwass, MS
    Zayek, MM
    Gross, I
    Heymann, MA
    Zapol, WM
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (09): : 605 - 610
  • [42] Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO)
    Seth, R.
    Atchley, W. T.
    Brewer, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [43] Do patient characteristics predict response to inhaled nitric oxide for neonatal persistent pulmonary hypertension?
    Everett, MF
    Kulik, TJ
    Schumacher, RE
    Becker, MA
    Nicks, JJ
    Bandy, KP
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1973 - 1973
  • [44] Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
    Kumar, Shine
    Memon, Danish
    Raj, Manu
    Sen, Amitabh C.
    Jayasankar, Jessin P.
    Leeladharan, Sreelakshmi P.
    Sudhakar, Abish
    Kumar, Raman K.
    PULMONARY CIRCULATION, 2022, 12 (04)
  • [45] Long term effects of perinatal hypoxia on estimated pulmonary arterial pressure in response to acute hypoxia and inhaled Nitric Oxide
    Muehlethaler, V
    Peyter, AC
    Liaudet, L
    Moessinger, A
    Tolsa, JF
    PEDIATRIC RESEARCH, 2003, 53 (04) : 432A - 432A
  • [46] Long-term survival in pulmonary arterial hypertension: the REVEAL registry
    Benza, R. L.
    Miller, D. P.
    Barst, R. J.
    Badesch, D. B.
    Frost, A. E.
    McGoon, M. D.
    EUROPEAN HEART JOURNAL, 2011, 32 : 676 - 676
  • [47] Inhaled nitric oxide and arterial oxygen tension in patients with chronic obstructive pulmonary disease and severe pulmonary hypertension
    Katayama, Y
    Higenbottam, TW
    deAtauri, MJD
    Cremona, G
    Akamine, S
    Barbera, JA
    RodriguezRoisin, R
    THORAX, 1997, 52 (02) : 120 - 124
  • [48] Long-term survival in pulmonary arterial hypertension: the REVEAL registry
    Benza, R. L.
    Miller, D. P.
    Barst, R. J.
    Badesch, D. B.
    Frost, A. E.
    McGoon, M. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 676 - 676
  • [49] Contribution of pulmonary surfactant with inhaled nitric oxide for treatment of pulmonary hypertension
    Kusuda, Satoshi
    Kim, Tae-Jang
    Koriyama, Takeshi
    Matsunami, Satoko
    Nakanishi, Hidehiko
    PEDIATRICS INTERNATIONAL, 2006, 48 (05) : 459 - 463
  • [50] Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension - Comparison with inhaled nitric oxide
    Michelakis, E
    Tymchak, W
    Lien, D
    Webster, L
    Hashimoto, K
    Archer, S
    CIRCULATION, 2002, 105 (20) : 2398 - 2403
12345